Data from digital health technologies (DHT), including wearable sensors like Apple Watch, Whoop, Oura Ring, and Fitbit, are increasingly being used in biomedical research. Research and development of DHT-related
2021年,美国FDA发布的关于“临床研究中远程数据采集的数字健康技术”(“Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”)的指南草案,被视为一个具有标志性意义的事件。 该指南提供了从使用DHTs的终点收集到临床试验中DHT的验...
in addition to providing benefits such as optimizing patient overall health status, improving clinician effectiveness and efficiency, lowering overall healthcare system costs, and providing public health and data science benefits2. DHTs that are regulated as, or function alongside, ...
Digital health technologies (DHTs) have brought several significant improvements to clinical trials, enabling real-world data collection outside of the traditional clinical context and more patient-centered approaches. DHTs, such as wearables, allow the collection of unique personal data at home over ...
Adding to that is the fact that several trials may need to integrate across multiple vendor solutions that can have different wearables/sensor integration patterns and needs. How can clinical trial technology companies leverage their partnership agreements to act as a DHT integration hub saving the ne...
systematic review aims to: (1) summarizing the type and source of data access from DHTs for COPD; (2) identifying the specific AI algorithms used within the digital health framework for COPD management; (3) and examining the key applications of AI algorithms in advancing digital health for ...
Digital health technologies and drug reimbursement As digital health technologies (DHTs) or "wearables" continue to advance, there are key considerations for drug sponsors to consider to ensure that the data generated by DHTs are acceptable to payers. ...
“data science, informatics, statistics, and mathematics to help ensure the appropriate application of AI technology in the context of DHTs used for drug development.” To that end, the agency commits to enhance its IT capabilities to receive and analyze large swaths of data used to support ...
of clinical decision support systems (CDSS) [7]. In addition, the adoption of international interoperability standards, such as Health Level Seven (HL7) Fast Healthcare Interoperability Resources (FHIR), is also necessary to allow efficient data exchange between information systems and new DHTs [8...
Increasing technological advances have the ability to impact many facets of drug development. Digital health technologies (DHTs) continue to improve the ability to reach more diverse patients, capture data continuously and passively outside traditional trial sites, and help create a more compreh...